# Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes

> **NCT00045305** · PHASE2 · COMPLETED · sponsor: **Eastern Cooperative Oncology Group** · enrollment: 17 (actual)

## Conditions studied

- Leukemia
- Myelodysplastic Syndromes
- Myelodysplastic/Myeloproliferative Neoplasms

## Interventions

- **DRUG:** Cyclosporine
- **DRUG:** Methotrexate
- **DRUG:** Photopheresis
- **DRUG:** Mycofenolate mofetil
- **DRUG:** Pentostatin
- **PROCEDURE:** allogeneic bone marrow
- **PROCEDURE:** peripheral blood stem cell
- **RADIATION:** Total body irradiation

## Key facts

- **NCT ID:** NCT00045305
- **Lead sponsor:** Eastern Cooperative Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10-24
- **Primary completion:** 2014-02
- **Final completion:** 2014-09
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2023-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00045305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00045305, "Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00045305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*